Sep 18, 2026•3 min read
Novartis Korea partners with Yuhan Yanghaeng to distribute LabsiDo for chronic urticaria
Novartis Korea and Yuhan Yanghaeng have signed a strategic partnership to handle distribution and promotion of LabsiDo (remibrutinib) for chronic spontaneous urticaria in South Korea.